A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment.

Alan K Burnett; Donald Milligan; Archie G Prentice; Anthony H Goldstone; Mary F McMullin; Robert K Hills; Keith Wheatley

doi:10.1002/cncr.22496

A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment.

Alan K Burnett, Donald Milligan, Archie G Prentice, Anthony H Goldstone, Mary F McMullin, Robert K Hills, Keith Wheatley

Research output: Contribution to journal › Article

412 Citations (Scopus)

Original language	English
Pages (from-to)	1114-1124
Number of pages	11
Journal	Cancer
Volume	109
Issue number	6
DOIs	https://doi.org/10.1002/cncr.22496
Publication status	Published - 15 Mar 2007

Keywords

Acute Disease
Aged
Antineoplastic Combined Chemotherapy Protocols
Cytarabine
Female
Humans
Hydroxyurea
Leukemia, Myeloid
Male
Middle Aged
Myelodysplastic Syndromes
Risk
Survival
Treatment Outcome
Tretinoin

Access to Document

10.1002/cncr.22496

Link to publication in Scopus

Cite this

Burnett, A. K., Milligan, D., Prentice, A. G., Goldstone, A. H., McMullin, M. F., Hills, R. K., & Wheatley, K. (2007). A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment. Cancer, 109(6), 1114-1124. https://doi.org/10.1002/cncr.22496

Burnett, Alan K ; Milligan, Donald ; Prentice, Archie G ; Goldstone, Anthony H ; McMullin, Mary F ; Hills, Robert K ; Wheatley, Keith. / A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment. In: Cancer. 2007 ; Vol. 109, No. 6. pp. 1114-1124.

@article{ce3caa6da0ad4ddf866fa6955d491865,

title = "A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment.",

keywords = "Acute Disease, Aged, Antineoplastic Combined Chemotherapy Protocols, Cytarabine, Female, Humans, Hydroxyurea, Leukemia, Myeloid, Male, Middle Aged, Myelodysplastic Syndromes, Risk, Survival, Treatment Outcome, Tretinoin",

author = "Burnett, {Alan K} and Donald Milligan and Prentice, {Archie G} and Goldstone, {Anthony H} and McMullin, {Mary F} and Hills, {Robert K} and Keith Wheatley",

year = "2007",

month = mar,

day = "15",

doi = "10.1002/cncr.22496",

language = "English",

volume = "109",

pages = "1114--1124",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "6",

}

Burnett, AK, Milligan, D, Prentice, AG, Goldstone, AH, McMullin, MF, Hills, RK & Wheatley, K 2007, 'A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment.', Cancer, vol. 109, no. 6, pp. 1114-1124. https://doi.org/10.1002/cncr.22496

A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment. / Burnett, Alan K; Milligan, Donald; Prentice, Archie G; Goldstone, Anthony H; McMullin, Mary F; Hills, Robert K; Wheatley, Keith.

In: Cancer, Vol. 109, No. 6, 15.03.2007, p. 1114-1124.

Research output: Contribution to journal › Article

TY - JOUR

T1 - A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment.

AU - Burnett, Alan K

AU - Milligan, Donald

AU - Prentice, Archie G

AU - Goldstone, Anthony H

AU - McMullin, Mary F

AU - Hills, Robert K

AU - Wheatley, Keith

PY - 2007/3/15

Y1 - 2007/3/15

KW - Acute Disease

KW - Aged

KW - Antineoplastic Combined Chemotherapy Protocols

KW - Cytarabine

KW - Female

KW - Humans

KW - Hydroxyurea

KW - Leukemia, Myeloid

KW - Male

KW - Middle Aged

KW - Myelodysplastic Syndromes

KW - Risk

KW - Survival

KW - Treatment Outcome

KW - Tretinoin

UR - http://www.scopus.com/inward/record.url?scp=33947205565&partnerID=8YFLogxK

U2 - 10.1002/cncr.22496

DO - 10.1002/cncr.22496

M3 - Article

C2 - 17279580

VL - 109

SP - 1114

EP - 1124

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 6

ER -